 Bondronat will bring relief to breast cancer sufferers |
Health chiefs have approved a breast cancer drug that will bring relief to thousands of sufferers in Scotland. Bondronat, which treats breast cancer that has spread to the bone, was evaluated by the Scottish Medicines Consortium (SMC).
The drug has been shown to prevent fractures and reduce the pain suffered by eight out of 10 patients.
Experts have said that it will improve the quality of life for Scotland's 40,000 breast cancer sufferers.
Dr David Cameron, consultant medical oncologist at Glasgow's Western General Infirmary, said the decision to approve the drug was "extremely welcome".
"Bondronat lets patients get on with their lives while taking pressure off cancer services in Scotland, and freeing up out-patient treatment resources," he said.
Its approval comes in the middle of Breast Cancer Awareness Month.
The Scottish Medicines Consortium, which provides advice to NHS bodies about new medications, said the drug met the criteria for use.
One-Minute World News 
News services
E-mail this to a friend 
Printable version 